Monday, November 24, 2014 4:26:04 PM
SLNX Press Release 10/27/14
Solanbridge Group Inc Announces the Departure of David M. Green
Former CEO finalizes retirement of shares
October 27, 2014
Houston – Solanbridge Group Inc (OTC: SLNX) is pleased to announce that Mr. David M. Green has decided to step down from all officer and director positions within the firm and pursue investment opportunities outside of Solanbridge.
Mr. Green previously had stepped down from the position of Chief Executive Officer on September 5, 2014.
Mr. Green has requested the stock transfer agent to finalize the cancellation of the 1.5 billion shares—the share cancellation previously announced. Mr. Green has pledged shareholder consent in support of the final cancellation.
Mr. Green will act as an outside consultant to Solanbridge for the next twelve months, pursuing real estate and medical marijuana opportunities in the State of Florida on a best efforts basis.
Charles R. Shirley, CEO of Solanbridge, stated, “We thank David for all of his service and look forward to his new relationship with Solanbridge.”
About Solanbridge Group Inc
Solanbridge Group Inc, based in Greater Houston, is a diversified holding company looking to expand into the medical marijuana industry by developing commercial grower’s licenses in Eastern Canadian medical marijuana jurisdictions, with the partnership of First Nations and developing CBD-infused products in Colorado and Nevada. Solanbridge is also pursuing other acquisitions in the growing medical marijuana field and partnerships with agribusiness entities.
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based upon the current beliefs and expectations of Solanbridge's management and are subject to significant risks and uncertainties. There can be no guarantees with respect to that the products will prove to be commercially successful. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Contact:
For further information, please contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
This release includes additional documents. Select the link(s) below to view.
NewsReleaseSLNXSolanbridgeDavidMGreen27Oct14.pdf
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM